2025. Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models. Journal of Kidney Cancer. 12, 3 (Sep. 2025), 58–65. DOI:https://doi.org/10.15586/jkcvhl.v12i3.427.